{"id":"W2774633492","doi":"10.1016/j.clcc.2017.12.003","title":"A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"F. Hoffmann-La Roche; Sanofi","keywords":"Irinotecan; Medicine; Oxaliplatin; Capecitabine; Internal medicine; Regimen; Colorectal cancer; Neutropenia; Oncology; Gastroenterology; Phases of clinical research; Toxicity; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002405815,0.001554235,0.002775159,0.0005966779,0.0005483697,0.0008779354,0.0009550278,0.001019408,0.001938045],"category_scores_gemma":[0.001115261,0.0008570265,0.001036611,0.0007495629,0.001319282,0.0008022445,0.0004079225,0.002831846,0.0004708495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008389513,"about_ca_system_score_gemma":0.00256497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008764455,"about_ca_topic_score_gemma":0.002097069,"domain_scores_codex":[0.9990748,0.0004856267,0.00005131625,0.0001353693,0.0001050666,0.0001478473],"domain_scores_gemma":[0.9990752,0.0001345672,0.0001482909,0.00005607489,0.0000452293,0.0005406045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5802897,0.1866496,0.02087872,0.001627639,0.001479101,0.001024851,0.000735753,0.00411172,0.0903651,0.0004606847,0.003768476,0.1086085],"study_design_scores_gemma":[0.4581801,0.5201056,0.01379379,0.00002787489,0.0003984999,0.000432499,0.00005234134,0.0009035649,0.003191198,0.0001295074,0.002755728,0.00002935361],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919618,0.002344024,0.000609272,0.0003545445,0.0001254161,0.003123954,0.0003485435,0.00004535882,0.001087093],"genre_scores_gemma":[0.9875809,0.002671286,0.002504891,0.0008578315,0.0002991085,0.003130173,0.001268936,0.00001974762,0.001667212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002775159,"threshold_uncertainty_score":0.01272333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03898936532661264,"score_gpt":0.4005475299049802,"score_spread":0.3615581645783675,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}